Form 8-K - Current report:
SEC Accession No. 0001398733-26-000029
Filing Date
2026-05-13
Accepted
2026-05-13 16:04:40
Documents
34
Period of Report
2026-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20260512.htm   iXBRL 8-K 56455
2 EX-99.1 q12026-ex991earningsrelease.htm EX-99.1 202111
3 EX-99.2 debtrefinancepressreleas.htm EX-99.2 9616
4 EX-99.3 earningsreleasesupplemen.htm EX-99.3 23250
8 aqstlogo.jpg GRAPHIC 14528
9 debtrefinancepressreleas001.jpg GRAPHIC 288338
10 debtrefinancepressreleas002.jpg GRAPHIC 299716
11 debtrefinancepressreleas003.jpg GRAPHIC 75962
12 earningsreleasesupplemen001.jpg GRAPHIC 109396
13 earningsreleasesupplemen002.jpg GRAPHIC 318181
14 earningsreleasesupplemen003.jpg GRAPHIC 150627
15 earningsreleasesupplemen004.jpg GRAPHIC 46076
16 earningsreleasesupplemen005.jpg GRAPHIC 104358
17 earningsreleasesupplemen006.jpg GRAPHIC 111172
18 earningsreleasesupplemen007.jpg GRAPHIC 108999
19 earningsreleasesupplemen008.jpg GRAPHIC 45502
20 earningsreleasesupplemen009.jpg GRAPHIC 101840
21 earningsreleasesupplemen010.jpg GRAPHIC 42052
22 earningsreleasesupplemen011.jpg GRAPHIC 82630
23 earningsreleasesupplemen012.jpg GRAPHIC 42226
24 earningsreleasesupplemen013.jpg GRAPHIC 70897
25 earningsreleasesupplemen014.jpg GRAPHIC 93687
26 earningsreleasesupplemen015.jpg GRAPHIC 62847
27 earningsreleasesupplemen016.jpg GRAPHIC 37241
  Complete submission text file 0001398733-26-000029.txt   3490010

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20260512.xsd EX-101.SCH 1776
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20260512_lab.xml EX-101.LAB 21629
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20260512_pre.xml EX-101.PRE 12504
37 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20260512_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 26973158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)